Jonathan Burdon

1.9k total citations · 1 hit paper
56 papers, 1.1k citations indexed

About

Jonathan Burdon is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Jonathan Burdon has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Jonathan Burdon's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Protease and Inhibitor Mechanisms (9 papers) and Peptidase Inhibition and Analysis (6 papers). Jonathan Burdon is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Protease and Inhibitor Mechanisms (9 papers) and Peptidase Inhibition and Analysis (6 papers). Jonathan Burdon collaborates with scholars based in Australia, United States and Canada. Jonathan Burdon's co-authors include Kenneth R. Chapman, Eeva Piitulainen, Niels Seersholm, Berend C. Stoel, Daniel Czarny, John B. Carlin, Roland Leung, Jonathan M. Edelman, Noel G. McElvaney and James Stocks and has published in prestigious journals such as The Lancet, JAMA and CHEST Journal.

In The Last Decade

Jonathan Burdon

54 papers receiving 1.1k citations

Hit Papers

Intravenous augmentation treatment and lung density in se... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
    2015 325 citations Kenneth R. Chapman, Jonathan Burdon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Burdon Australia 18 435 278 268 206 170 56 1.1k
Francesca Lunardi Italy 21 683 1.6× 329 1.2× 132 0.5× 185 0.9× 249 1.5× 94 1.6k
Jun Ah Lee South Korea 22 543 1.2× 261 0.9× 132 0.5× 73 0.4× 236 1.4× 84 1.3k
Frank D. Groves United States 18 255 0.6× 445 1.6× 88 0.3× 54 0.3× 160 0.9× 40 1.5k
Richard Brasington United States 22 398 0.9× 146 0.5× 44 0.2× 170 0.8× 158 0.9× 41 1.7k
Stefan Hacker Austria 26 254 0.6× 336 1.2× 91 0.3× 111 0.5× 426 2.5× 70 1.7k
Kun‐Yun Yeh Taiwan 24 302 0.7× 777 2.8× 162 0.6× 296 1.4× 306 1.8× 125 1.6k
Camilla Bengtsson Sweden 28 455 1.0× 190 0.7× 55 0.2× 240 1.2× 239 1.4× 52 3.3k
Christian Schulz Germany 17 612 1.4× 305 1.1× 79 0.3× 180 0.9× 132 0.8× 61 1.0k
John Lazarchick United States 25 260 0.6× 228 0.8× 58 0.2× 94 0.5× 186 1.1× 135 2.0k
Damien Dietrich Switzerland 15 224 0.5× 527 1.9× 138 0.5× 54 0.3× 214 1.3× 26 1.1k

Countries citing papers authored by Jonathan Burdon

Since Specialization
Citations

This map shows the geographic impact of Jonathan Burdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Burdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Burdon more than expected).

Fields of papers citing papers by Jonathan Burdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Burdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Burdon. The network helps show where Jonathan Burdon may publish in the future.

Co-authorship network of co-authors of Jonathan Burdon

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Burdon. A scholar is included among the top collaborators of Jonathan Burdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Burdon. Jonathan Burdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burdon, Jonathan, Lygia Therese Budnik, Xaver Baur, et al.. (2023). Health consequences of exposure to aircraft contaminated air and fume events: a narrative review and medical protocol for the investigation of exposed aircrew and passengers. Environmental Health. 22(1). 43–43. 17 indexed citations
2.
Roig, Jorge, Christian Domingo, Jonathan Burdon, & Susan Michaelis. (2021). Irritant-induced Asthma Caused by Aerotoxic Syndrome. Lung. 199(2). 165–170. 6 indexed citations
3.
Hoy, Ryan, Jonathan Burdon, Ling Chen, et al.. (2020). Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia. Respirology. 25(11). 1183–1192. 11 indexed citations
4.
Chapman, Kenneth R., Jonathan Burdon, Eeva Piitulainen, et al.. (2015). Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. The Lancet. 386(9991). 360–368. 325 indexed citations breakdown →
5.
Burdon, Jonathan. (2015). Adult-onset asthma.. PubMed. 44(8). 554–7. 6 indexed citations
6.
Sandhaus, Robert A., Kenneth R. Chapman, Jonathan Burdon, et al.. (2014). Integrated safety across six clinical trials of alpha-1 augmentation therapy. European Respiratory Journal. 44(Suppl 58). P950–P950. 2 indexed citations
7.
Stocks, James, Robert A. Sandhaus, Kenneth R. Chapman, et al.. (2014). Baseline Patient Demographics and Lung Density Decline in the RAPID Trial. CHEST Journal. 146(4). 71A–71A. 1 indexed citations
8.
Stolk, Jan, Robert A. Stockley, Berend C. Stoel, et al.. (2012). Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. European Respiratory Journal. 40(2). 306–312. 63 indexed citations
9.
Pierce, Robert J., David R. Hillman, Iven H Young, et al.. (2005). Respiratory function tests and their application. Respirology. 10(s2). S1–19. 13 indexed citations
10.
Burdon, Jonathan, et al.. (2002). Decline in FEV1 in patients with PiZ alpha‐1‐antitrypsin deficiency: The Australian experience. Respirology. 7(1). 51–55. 3 indexed citations
11.
Wood‐Baker, Richard, et al.. (2001). Fibre‐optic bronchoscopy in adults: a position paper of The Thoracic Society of Australia and New Zealand. Internal Medicine Journal. 31(8). 479–487. 31 indexed citations
12.
Burdon, Jonathan, et al.. (1998). COMPARISON OF EFFICACY AND EASE OF HANDLING OF SALMETEROL AND TERBUTALINE POWDER INHALERS. International Journal of Clinical Practice. 52(2). 85–88. 4 indexed citations
13.
Knight, Kenneth R., et al.. (1997). The proteinase–antiproteinase theory of emphysema: A speculative analysis of recent advances into the pathogenesis of emphysema. Respirology. 2(2). 91–95. 19 indexed citations
14.
Abramson, Michael J., et al.. (1996). Evaluation of impairment, disability and handicap caused by respiratory disease. Australian and New Zealand Journal of Medicine. 26(5). 697–701. 1 indexed citations
15.
Burdon, Jonathan, et al.. (1996). Antiproteinase deficiency, emphysema and replacement therapy. Australian and New Zealand Journal of Medicine. 26(6). 769–771. 3 indexed citations
16.
Burdon, Jonathan, et al.. (1995). Alpha‐1‐antitrypsin PLowell: a normally functioning variant present in low concentration. Australian and New Zealand Journal of Medicine. 25(6). 695–697. 7 indexed citations
17.
Janus, Edward, et al.. (1994). Absence of alpha‐1‐antitrypsin (Pi Null Bellingham) and the early onset of emphysema. Australian and New Zealand Journal of Medicine. 24(3). 263–269. 10 indexed citations
18.
Burdon, Jonathan, et al.. (1990). The ‘shrinking lungs syndrome’—an infrequently recognised feature of systemic lupus erythematosus. Australian and New Zealand Journal of Medicine. 20(1). 67–70. 23 indexed citations
19.
Hayes, John A., et al.. (1988). Deoxyhaemoglobin concentrations in the detection of central cyanosis.. Thorax. 43(3). 212–213. 11 indexed citations
20.
Stevens, Wendy, Jonathan Burdon, & J. F. Niall. (1987). Pleural effusion after rupture of silicone bag mammary prosthesis.. Thorax. 42(10). 825–826. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Lunardi Breakdown of academic impact, for papers by Jun Ah Lee Breakdown of academic impact, for papers by Frank D. Groves Breakdown of academic impact, for papers by Richard Brasington Breakdown of academic impact, for papers by Stefan Hacker Breakdown of academic impact, for papers by Kun‐Yun Yeh Breakdown of academic impact, for papers by Camilla Bengtsson Breakdown of academic impact, for papers by Christian Schulz Breakdown of academic impact, for papers by John Lazarchick Breakdown of academic impact, for papers by Damien Dietrich
Rankless by CCL
2026